Carles Pericay Selected Research

Diarrhea

10/2014	Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial.
12/2013	Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carles Pericay Research Topics

Disease

16	Neoplasms (Cancer) 10/2023 - 02/2010
15	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 01/2010
7	Adenocarcinoma 02/2024 - 10/2014
7	Rectal Neoplasms (Rectal Cancer) 12/2023 - 02/2010
5	Neoplasm Metastasis (Metastasis) 09/2021 - 10/2015
4	Disease Progression 09/2021 - 01/2010
4	Stomach Neoplasms (Stomach Cancer) 06/2018 - 08/2009
2	Diarrhea 10/2014 - 12/2013
1	Thrombocytopenia (Thrombopenia) 02/2024
1	Neutropenia 02/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024
1	Microsatellite Instability 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Surgical Wound Infection 01/2016
1	Anastomotic Leak 10/2014
1	Pulmonary Embolism 10/2014
1	Peritonitis 10/2014
1	Fatigue 12/2013
1	Breast Neoplasms (Breast Cancer) 04/2007
1	Pathologic Complete Response 04/2007

Drug/Important Bio-Agent (IBA)

10	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 02/2010
8	Capecitabine (Xeloda)FDA Link 12/2023 - 08/2009
7	Bevacizumab (Avastin)FDA Link 11/2020 - 01/2011
7	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2010
6	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 09/2012
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2013
5	Leucovorin (Folinic Acid)FDA Link 02/2024 - 12/2013
5	MicroRNAs (MicroRNA)IBA 06/2018 - 07/2013
4	Cetuximab (Erbitux)FDA Link 10/2015 - 01/2010
3	afliberceptIBA 12/2023 - 09/2015
3	ErbB Receptors (EGF Receptor)IBA 09/2023 - 04/2011
3	XELOXIBA 08/2020 - 01/2011
3	Panitumumab (Vectibix)FDA Link 01/2019 - 10/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 11/2019
2	trifluridine tipiracil drug combinationIBA 01/2022 - 09/2021
2	ParaffinIBA 10/2020 - 07/2013
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 08/2009
2	RNA (Ribonucleic Acid)IBA 01/2016 - 12/2015
1	Gemcitabine FDA Link 02/2024
1	130-nm albumin-bound paclitaxelIBA 02/2024
1	Alkaline PhosphataseIBA 09/2021
1	Circulating Tumor DNAIBA 01/2021
1	Trinitrotoluene (TNT)IBA 01/2021
1	Long Noncoding RNAIBA 10/2020
1	Lapatinib (GW572016)FDA Link 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	Circulating MicroRNAIBA 06/2018
1	RamucirumabIBA 12/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2016
1	Tryptophan (L-Tryptophan)FDA Link 01/2016
1	KynurenineIBA 01/2016
1	Monoclonal AntibodiesIBA 10/2015
1	Axitinib (AG 013736)IBA 12/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2013
1	Formaldehyde (Formol)FDA Link 07/2013
1	Tumor Biomarkers (Tumor Markers)IBA 07/2013
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 04/2011
1	Cisplatin (Platino)FDA LinkGeneric 08/2009
1	AnthracyclinesIBA 04/2007
1	Taxoids (Taxanes)IBA 04/2007
1	Estrogen ReceptorsIBA 04/2007
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2007

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 09/2023 - 04/2007
12	Therapeutics 04/2022 - 01/2011
5	Chemoradiotherapy 11/2020 - 02/2010
4	Neoadjuvant Therapy 12/2023 - 11/2019
4	Radiotherapy 12/2023 - 07/2020
2	Immunotherapy 08/2023 - 01/2020
2	Induction Chemotherapy 11/2019 - 01/2011
1	Metastasectomy 10/2023
1	Drug Tapering 09/2021
1	Salvage Therapy 01/2019
1	Conversion to Open Surgery 01/2016
1	Length of Stay 01/2016
1	Adjuvant Chemotherapy 02/2010